查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497663

生物标记市场：按产品/服务、类型、疾病、应用分类 - 全球预测 2024-2030

Biomarkers Market by Product & Service (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年生物标记市场规模为525亿美元，预计2024年将达596.9亿美元，2030年将达到1329.8亿美元，复合年增长率为14.19%。

生物标记物也称为生物标誌物，是生物状况或状况的可测量指标，通常在体液和组织中被检测和量化。由于它可以反映各种生理和病理过程的存在，因此在医学领域中广泛应用，如诊断疾病、预测治疗效果、监测疾病进展等。生物标记的广泛使用主要是由于慢性病盛行率的不断上升以及对个人化医疗的日益重视，个人化医疗根据个人特征、行为和风险因素制定治疗方案。然而，生物标誌物开发的挑战包括发现和检验的高成本和复杂性、监管障碍以及需要强大的临床检验以确保可靠性和有效性。儘管存在这些挑战，针对新出现的健康威胁的新生物标誌物的开发、药物开发过程中对生物标誌物的关注以及人工智慧的整合以改善生物标誌物的发现和应用仍在继续，为更准确、更有效的医疗保健解决方案铺平了道路。

主要市场统计
基准年[2023] 525亿美元
预测年份 [2024] 596.9亿美元
预测年份 [2030] 1329.8亿美元
复合年增长率（%） 14.19%

区域洞察

由于先进的医疗基础设施和研发投资，美洲生物标记市场呈现强劲成长。美国透过在临床实践中大规模采用生物标誌物以及对生物标誌物研究的强有力的机构支持，为这一增长做出了重大贡献。此外，慢性病盛行率的增加和对个人化医疗的浓厚兴趣是推动市场成长的主要因素。由于高额医疗保健支出和较早采用新技术，欧洲市场呈现稳定成长。由于医疗基础设施的改善以及对个人化医疗益处的认识不断提高，中东和非洲显示出成长潜力。由于经济的快速开拓、医疗保健支出的增加以及政府对医疗保健系统现代化的努力，亚太地区的生物标记市场呈现快速成长。人口增长和疾病发病率增加促进了生物标誌物的采用。此外，该地区生物技术公司和研究机构的扩张进一步支持了成长。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在生物标记物市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对生物标记物市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在生物标誌物市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 更多使用生物标记来早期检测和诊断慢性病
      • 政府和监管机构对生物标记研究的支持
      • 扩大生物标记在个人化医疗的应用
    • 抑制因素
      • 与生物标誌物开发相关的高成本和技术问题
    • 机会
      • 将生物标记物与人工智慧和机器学习结合
      • 人们对开发先进的非侵入性生物标记越来越感兴趣
    • 任务
      • 关于使用生物标誌物的伦理和法律问题
  • 市场区隔分析
    • 产品和服务：越来越多地采用先进且易于使用的生物标记软体来处理复杂的生物资料。
    • 应用：增加生物标记的应用以确定药物开发中的产品功效和安全性
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依产品/服务分類的生物标记市场

  • 消耗品
  • 服务
  • 软体

第七章生物标誌物市场：依类型

  • 功效生物标记
  • 安全生物标记
  • 检验生物标记

第八章生物标记市场：依疾病分类

  • 癌症
  • 心血管疾病
  • 免疫疾病
  • 感染疾病
  • 神经系统疾病

第九章生物标记市场：依应用分类

  • 临床诊断
  • 临床调查
  • 药物发现与开发
  • 个人化医疗

第10章美洲生物标记市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生物标记市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的生物标记市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Owlstone Medical 的创新计画获得比尔及梅琳达盖兹基金会的资助
    • 开创性研究合作加强转移性大肠直肠癌的治疗
    • FDA 启动试验计画来监管肿瘤药物的伴同性诊断测试
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEFACD9

[195 Pages Report] The Biomarkers Market size was estimated at USD 52.50 billion in 2023 and expected to reach USD 59.69 billion in 2024, at a CAGR 14.19% to reach USD 132.98 billion by 2030.

Biomarkers, also known as biological markers, a measurable indicators of some biological state or condition, often detected and quantified in body fluids or tissues. They are extensively used in medical science for diagnosing diseases, predicting treatment response, and monitoring the progress of disease, owing to their ability to reflect the presence of various physiological or pathological processes. The expansion of their use is primarily driven by the increasing prevalence of chronic diseases and a growing appreciation for personalized medicine, which tailors treatment to individual characteristics, behaviors, and risk factors. However, challenges in biomarker development include the high cost and complexity of discovery and validation, along with regulatory hurdles and the necessity for robust clinical validation to ensure reliability and efficacy. Despite these challenges, the development of novel biomarkers for emerging health threats, enhanced focus on biomarkers in drug development processes, and the integration of artificial intelligence to improve biomarker discovery and application pave the way for more precise and effective healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 52.50 billion
Estimated Year [2024] USD 59.69 billion
Forecast Year [2030] USD 132.98 billion
CAGR (%) 14.19%

Regional Insights

The biomarker market in the Americas is showing robust growth, with the presence of advanced healthcare infrastructure and investment in research and development. The United States is the major contributor to this growth, driven by the large-scale implementation of biomarkers in clinical practices and strong support from government entities for biomarker research. Additionally, the increasing prevalence of chronic diseases and a strong focus on personalized medicine are major factors propelling market growth. Europe is displaying steady market growth owing to high healthcare spending and early adoption of new technologies. The Middle East and Africa are showing growth potential due to improving healthcare infrastructure and growing awareness about the benefits of personalized medicine. Asia-Pacific showcases rapid growth in the biomarker market, facilitated by rapid economic development, increasing healthcare expenditure, and government initiatives aimed at modernizing healthcare systems. Growing populations and increasing incidence of diseases contribute to the adoption of biomarkers. Moreover, the expansion of biotechnology companies and research institutions in this region further supports the growth.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biomarkers Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing usage of biomarkers in early detection and diagnosis of chronic disease
      • Governments and regulatory support for biomarker research
      • Growing applications of biomarkers in personalized medicine
    • Market Restraints
      • High cost and technical issues associated with developing biomarkers
    • Market Opportunities
      • Integration of biomarkers with artificial intelligence and machine learning
      • Growing interest in developing advanced noninvasive biomarkers
    • Market Challenges
      • Ethical and legal concerns regarding the use of biomarkers
  • Market Segmentation Analysis
    • Product & Service: Growing adoption of sophisticated and user-friendly biomarker software to handle the complexity of biological data
    • Application: Growing applications of biomarkers in drug development to determine the efficacy and safety of the product
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biomarkers Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biomarkers Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Owlstone Medical's Novel Initiatives Receive the Bill & Melinda Gates Foundation Funding

Owlstone Medical has received significant financial funding from the Bill & Melinda Gates Foundation to enhance early disease detection using its innovative Breath Biopsy platform. This includes a USD 5 million equity investment and an additional USD 1.5 million in grant funding. The grant is focused on identifying volatile organic compound (VOC) biomarkers for tuberculosis (TB) and human immunodeficiency virus (HIV). [Published On: 2024-04-25]

Pioneering Research Collaboration to Enhance Treatment for Metastatic Colorectal Cancer

The National Comprehensive Cancer Network (NCCN) has collaborated with Fight Colorectal Cancer (Fight CRC) and Pfizer to provide funding aimed at advancing biomarker-directed therapies for metastatic colorectal cancer. This significant financial support is designated for innovative clinical studies that are focused on identifying and utilizing biomarkers to improve the effectiveness and precision of treatments for patients battling this advanced stage of colorectal cancer. [Published On: 2023-08-09]

FDA Initiates Pilot Program to Regulate Companion Diagnostic Tests for Oncology Drugs

The U.S. Food and Drug Administration (FDA) has introduced a pivotal pilot program focused on refining the integration of specific oncology drugs with their corresponding in-vitro diagnostic tests. This initiative primarily addresses the critical use of laboratory-developed tests (LDTs) to identify specific biomarkers used for selecting cancer treatment. The program aims to establish and make public the minimum performance characteristics necessary for diagnostic tests utilized in clinical trials. [Published On: 2023-06-21]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biomarkers Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biomarkers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, APIS Assay Technologies Limited, Augurex Life Sciences Corp, Bio-Rad Laboratories, Inc., BioAgilytix, Biocrates Life Sciences AG, Biofourmis Inc., Biognosys AG, BioStarks, Charles River Laboratories, Inc., Elo Health, Inc., F. Hoffmann-La Roche, Ltd., Merck KgaA, Nightingale Health Plc, Owkin Inc., Owlstone Medical Limited, PerkinElmer, Inc., Personalis, Inc., Proteomedix AG, QIAGEN GmbH, Siemens Healthineers AG, Sino Biological Inc., Thermo Fisher Scientific, Inc., and VivoSense, Inc.

Market Segmentation & Coverage

This research report categorizes the Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Consumables
    • Services
    • Software
  • Type
    • Efficacy Biomarkers
      • Pharmacodynamic Biomarkers
      • Predictive Biomarkers
      • Prognostic Biomarkers
      • Surrogate Biomarkers
    • Safety Biomarkers
    • Validation Biomarkers
  • Disease
    • Cancer
    • Cardiovascular Diseases
    • Immunological Diseases
    • Infectious Diseases
    • Neurological Diseases
  • Application
    • Clinical Diagnostics
    • Clinical Research
    • Drug Discovery & Development
    • Personalized Medicine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing usage of biomarkers in early detection and diagnosis of chronic disease
      • 5.1.1.2. Governments and regulatory support for biomarker research
      • 5.1.1.3. Growing applications of biomarkers in personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and technical issues associated with developing biomarkers
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of biomarkers with artificial intelligence and machine learning
      • 5.1.3.2. Growing interest in developing advanced noninvasive biomarkers
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and legal concerns regarding the use of biomarkers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Growing adoption of sophisticated and user-friendly biomarker software to handle the complexity of biological data
    • 5.2.2. Application: Growing applications of biomarkers in drug development to determine the efficacy and safety of the product
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biomarkers Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Services
  • 6.4. Software

7. Biomarkers Market, by Type

  • 7.1. Introduction
  • 7.2. Efficacy Biomarkers
  • 7.3. Safety Biomarkers
  • 7.4. Validation Biomarkers

8. Biomarkers Market, by Disease

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Cardiovascular Diseases
  • 8.4. Immunological Diseases
  • 8.5. Infectious Diseases
  • 8.6. Neurological Diseases

9. Biomarkers Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Clinical Research
  • 9.4. Drug Discovery & Development
  • 9.5. Personalized Medicine

10. Americas Biomarkers Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomarkers Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomarkers Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Owlstone Medical's Novel Initiatives Receive the Bill & Melinda Gates Foundation Funding
    • 13.3.2. Pioneering Research Collaboration to Enhance Treatment for Metastatic Colorectal Cancer
    • 13.3.3. FDA Initiates Pilot Program to Regulate Companion Diagnostic Tests for Oncology Drugs
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOMARKERS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMARKERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMARKERS MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMARKERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMARKERS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOMARKERS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMARKERS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOMARKERS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACODYNAMIC BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACODYNAMIC BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMARKERS MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOMARKERS MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMARKERS MARKET SIZE, BY PROGNOSTIC BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOMARKERS MARKET SIZE, BY PROGNOSTIC BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMARKERS MARKET SIZE, BY SURROGATE BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOMARKERS MARKET SIZE, BY SURROGATE BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMARKERS MARKET SIZE, BY SAFETY BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOMARKERS MARKET SIZE, BY SAFETY BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMARKERS MARKET SIZE, BY VALIDATION BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOMARKERS MARKET SIZE, BY VALIDATION BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMARKERS MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOMARKERS MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMARKERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOMARKERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 138. AUSTRALIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. AUSTRALIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 147. CHINA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 148. CHINA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 149. CHINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. CHINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 157. INDIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 158. INDIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 159. INDIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 167. INDONESIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 168. INDONESIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 169. INDONESIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. INDONESIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 177. JAPAN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 178. JAPAN BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 179. JAPAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. JAPAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 187. MALAYSIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 188. MALAYSIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 189. MALAYSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. MALAYSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 198. PHILIPPINES BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. PHILIPPINES BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 207. SINGAPORE BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 208. SINGAPORE BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 209. SINGAPORE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SINGAPORE BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 218. SOUTH KOREA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. SOUTH KOREA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 227. TAIWAN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 228. TAIWAN BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 229. TAIWAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. TAIWAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 237. THAILAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 238. THAILAND BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 239. THAILAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. THAILAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 247. VIETNAM BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 248. VIETNAM BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 249. VIETNAM BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. VIETNAM BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 269. DENMARK BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 270. DENMARK BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 271. DENMARK BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. DENMARK BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 279. EGYPT BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 280. EGYPT BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 281. EGYPT BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. EGYPT BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 289. FINLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 290. FINLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 291. FINLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FINLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 299. FRANCE BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 300. FRANCE BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 301. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 309. GERMANY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 310. GERMANY BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 311. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 319. ISRAEL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 320. ISRAEL BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 321. ISRAEL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ISRAEL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 329. ITALY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 330. ITALY BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 331. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 339. NETHERLANDS BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 340. NETHERLANDS BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 341. NETHERLANDS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. NETHERLANDS BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 349. NIGERIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 350. NIGERIA BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 351. NIGERIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. NIGERIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 359. NORWAY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 360. NORWAY BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 361. NORWAY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. NORWAY BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 369. POLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 370. POLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 371. POLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. POLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR BIOMARKERS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR BIOMARKERS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2018-2023 (USD MILLION)
  • TABLE 378. QATAR BIOMARKERS MARKET SIZE, BY EFFICACY BIOMARKERS, 2024-2030 (USD MILLION)
  • TABLE 379. QATAR BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
  • TABLE 380. QATAR BIOMARKERS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
  • TABLE 381. QATAR BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 382. QATAR BIOMARKERS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA BIOMARKERS MARKET SIZE,